301 related articles for article (PubMed ID: 32187383)
1. Small-Bowel Adaptation: A Case of Morphological Changes Induced by Teduglutide in Short-Bowel Syndrome With Intestinal Failure.
Mouillot T; Boehm V; Treton X; Ferrandi E; Kapel N; Cazals-Hatem D; Joly F
JPEN J Parenter Enteral Nutr; 2020 Jul; 44(5):940-943. PubMed ID: 32187383
[TBL] [Abstract][Full Text] [Related]
2. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome.
Thymann T; Stoll B; Mecklenburg L; Burrin DG; Vegge A; Qvist N; Eriksen T; Jeppesen PB; Sangild PT
J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211
[TBL] [Abstract][Full Text] [Related]
4. Treatment of adult short bowel syndrome patients with teduglutide.
Nørholk LM; Holst JJ; Jeppesen PB
Expert Opin Pharmacother; 2012 Feb; 13(2):235-43. PubMed ID: 22224470
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
[TBL] [Abstract][Full Text] [Related]
6. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
[TBL] [Abstract][Full Text] [Related]
7. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
[TBL] [Abstract][Full Text] [Related]
8. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
Iturrino J; Camilleri M; Acosta A; O'Neill J; Burton D; Edakkanambeth Varayil J; Carlson PJ; Zinsmeister AR; Hurt R
JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1089-1095. PubMed ID: 26223941
[TBL] [Abstract][Full Text] [Related]
9. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
Yazbeck R
Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
Ukleja A; To C; Alvarez A; Lara LF
JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
[TBL] [Abstract][Full Text] [Related]
11. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
[TBL] [Abstract][Full Text] [Related]
12. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
[TBL] [Abstract][Full Text] [Related]
13. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
Kochar B; Herfarth HH
Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
[TBL] [Abstract][Full Text] [Related]
14. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
Tappenden KA; Edelman J; Joelsson B
J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
[TBL] [Abstract][Full Text] [Related]
15. The indications and results of the use of teduglutide in patients with short bowel.
El Khatib M; Billiauws L; Joly F
Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
[TBL] [Abstract][Full Text] [Related]
16. New approaches to the treatments of short bowel syndrome-associated intestinal failure.
Jeppesen PB
Curr Opin Gastroenterol; 2014 Mar; 30(2):182-8. PubMed ID: 24406477
[TBL] [Abstract][Full Text] [Related]
17. Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure.
Martin A; Boehm V; Zappa M; Billiauws L; Bonvalet F; Nuzzo A; Vilgrain V; Joly F; Ronot M
Am J Clin Nutr; 2021 May; 113(5):1343-1350. PubMed ID: 33675349
[TBL] [Abstract][Full Text] [Related]
18. Teduglutide for treatment of adult patients with short bowel syndrome.
Billiauws L; Bataille J; Boehm V; Corcos O; Joly F
Expert Opin Biol Ther; 2017 May; 17(5):623-632. PubMed ID: 28293969
[TBL] [Abstract][Full Text] [Related]
19. Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
Sato T; Uchino M; Takeuchi J; Fujihira Y; Shimizu K; Yokoyama K; Yagi S; Kaku K; Takashima Y; Ikenouchi M; Kojima K; Kawai M; Nagase K; Kamikozuru K; Yokoyama Y; Takagawa T; Ikeuchi H; Watanabe K; Shinzaki S
Clin Nutr; 2023 May; 42(5):722-731. PubMed ID: 37001195
[TBL] [Abstract][Full Text] [Related]
20. Intestinal iatrogenic hyperadaptation in patients with short bowel syndrome and Crohn's disease: Is this an indication for mandatory lifelong injections of teduglutide?
Mazzuoli S; Regano N; Lamacchia S; Silvestri A; Guglielmi FW
Nutrition; 2021; 91-92():111396. PubMed ID: 34399400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
